ArticleJournal of clinical medicine2026

The Contribution of Dostarlimab to First-Line Treatment of Advanced or Recurrent Endometrial Cancer in Spain: A Multi-Criteria Decision Analysis Approach.

Maria-Pilar Barretina-Ginesta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.